Move your pipeline more efficiently. RISA Bio combines deep oncology expertise with AI-native infrastructure to accelerate every stage of clinical development.
Built by RISA Labs
The Problem
Oncology trials are uniquely complex. Fragmented data, slow site activation, and manual processes delay the therapies patients need most.
Services
From protocol optimization to regulatory submission, we deploy AI where it matters most -- accelerating timelines without compromising rigor.
AI-driven protocol authoring informed by real-world evidence, published trial data, and guideline analysis. Reduce amendments, improve enrollment feasibility.
Identify high-performing oncology sites using real-time data signals -- patient volume, investigator experience, competitive trial landscape, and enrollment velocity.
AI-powered patient matching across EMR, claims, and genomic data. Connect eligible patients to the right trials faster, with fewer screen failures.
Automated data capture, cleaning, and reconciliation. AI models flag anomalies in real time, reducing query cycles and accelerating database lock.
Navigate FDA pathways with confidence. AI-assisted dossier preparation, clinical study reports, and submission-ready documentation aligned to current guidance.
Generate insights from claims, EMR, and registry data. Support label expansion, comparative effectiveness, and post-market surveillance with structured evidence.
How It Works
We don't bolt AI onto legacy processes. Our platform is built from the ground up to make clinical research faster, smarter, and more predictable.
Share your therapeutic target, indication, and development stage. We map the landscape -- competitive trials, guideline context, patient populations, and site options.
Our AI agents work across protocol design, site selection, patient matching, and data management -- compressing months of manual work into weeks.
You get faster enrollment, cleaner data, and a clear regulatory path. We stay embedded through submission, adapting as your trial evolves.
Why RISA Bio
We started in oncology workflow automation. We understand the clinical, regulatory, and operational complexity of cancer care -- because it's all we do.
Our models are trained on oncology workflows, NCCN/ASCO guidelines, and real clinical data. Not generic AI adapted for healthcare -- purpose-built for cancer research.
AI handles the high-volume, repetitive work -- data extraction, matching, anomaly detection -- so your team focuses on science and strategy.
We draw from RISA's oncology network -- cancer centers, investigators, and market intelligence -- to give you a structural advantage in site and patient access.
Every output is auditable and traceable. AI recommendations include evidence citations, confidence scores, and human review checkpoints. No black boxes.
Therapeutic Focus
We support clinical development across solid tumors and hematologic malignancies, with particular depth in high-complexity indications.
Get Started
Whether you're designing a first-in-human trial or expanding a label, RISA Bio can help you move faster with better data. Let's talk.
Talk to Us